Kansas State University
1105 Sunset Avenue
Manhattan, KS 66502-3761
785-532-6544
lafene@k-state.edu
Treatment of Attention Deficit Disorder (ADD) by Lafene Health Center Staff
February 1, 2006
Lafene Health Center policy number 30-058 requires all patients presenting for treatment with symptoms and/or signs suggestive of ADD or for refills on Schedule II stimulant medications prescribed for ADD (e.g. Adderall, Ritalin, Concerta) to be thoroughly evaluated and provide documentation of a definitive diagnosis of ADD prior to receiving a prescription from a Lafene provider for any of these medications. As there is no single "gold standard" diagnostic test, it is the responsibility of the provider evaluating the patient for ADD to determine which specific tests are necessary. However, it is required that the comprehensive diagnostic evaluation shall include the following components:
- Clinical interview to include developmental history and assessment of the impact the student's symptoms have on current school, occupational and relationship functioning.
- Assessment of attention, concentration, distractibility and short-term memory.
- Cognitive and achievement tests.
- Assessment for presence of other psychiatric disorders and substance abuse.
- Medical examination including any appropriate laboratory tests.
Please contact the Medical Director at Lafene Health Center for clarification or further information, if needed.
Lannie Zweimiller, Director
Robert Tackett, Medical Director
